Cargando…

Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study

INTRODUCTION: This pilot study evaluated the impact of a diabetes-specific nutritional shake (DSNS) used twice daily by people with type 2 diabetes (T2D) on glycemic response assessed by continuous glucose monitoring (CGM). RESEARCH DESIGN AND METHODS: Adults (n=81) with T2D managed by oral medicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustad, Vikkie A, Hegazi, Refaat A, Hustead, Deborah S, Budiman, Erwin S, Rueda, Ricardo, Maki, Kevin, Powers, Margaret, Mechanick, Jeffrey I, Bergenstal, Richard M, Hamdy, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389484/
https://www.ncbi.nlm.nih.gov/pubmed/32718934
http://dx.doi.org/10.1136/bmjdrc-2020-001258
_version_ 1783564409010913280
author Mustad, Vikkie A
Hegazi, Refaat A
Hustead, Deborah S
Budiman, Erwin S
Rueda, Ricardo
Maki, Kevin
Powers, Margaret
Mechanick, Jeffrey I
Bergenstal, Richard M
Hamdy, Osama
author_facet Mustad, Vikkie A
Hegazi, Refaat A
Hustead, Deborah S
Budiman, Erwin S
Rueda, Ricardo
Maki, Kevin
Powers, Margaret
Mechanick, Jeffrey I
Bergenstal, Richard M
Hamdy, Osama
author_sort Mustad, Vikkie A
collection PubMed
description INTRODUCTION: This pilot study evaluated the impact of a diabetes-specific nutritional shake (DSNS) used twice daily by people with type 2 diabetes (T2D) on glycemic response assessed by continuous glucose monitoring (CGM). RESEARCH DESIGN AND METHODS: Adults (n=81) with T2D managed by oral medications were studied in a randomized, open-label, three-group parallel study design. The study was conducted in two phases over 14 days: Baseline (days 1–6), during which study participants consumed their habitual self-selected diets (SSD), followed by the Intervention (days 7–14), during which participants were randomized as follows: (1) SSD group received no study product (n=32); (2) DSNS breakfast/afternoon snack (Bkfst/AS) group consumed one DSNS as a breakfast meal replacement and a second to replace their mid-afternoon snack (n=24); (3) DSNS breakfast/prebed snack (Bkfst/PBS) group consumed one DSNS as a breakfast meal replacement and added a second as a prebed snack (n=25). Glucose was assessed by CGM throughout the study. Additionally, participants were asked about snacking behaviors, cravings, and other questions related to the use of DSNS as meal replacements and snacks. RESULTS: All groups reduced their postprandial glycemic response (positive area under the curve (pAUC, mg/min*dL(−1))) and adjusted peak value (mg/dL) when compared with the baseline phase. Participants consuming DSNS in place of their usual breakfast showed greater reductions in pAUC compared with the SSD group (p=0.008) for the DSNS Bkfst/AS group with a trend (p=0.069) for the DSNS Bkfst/PBS group. Adjusted peak value showed greater reductions in both DSNS groups as compared with the SSD group (p=0.002 for DSNS Bkfst/AS and p=0.010 for DSNS Bkfst/PBS). Nocturnal glucose variability was significantly decreased during the intervention phase compared with baseline phase in the DSNS Bkfst/AS group (p=0.020), with no significant differences between groups. After intervention, the DSNS Bkfst/AS group had a significantly lower percentage of participants (17%) reporting cravings for starchy meals/sides compared with before the study (33%) (p=0.046). This group also reported a significant increase in confidence in choosing foods to control their diabetes (from 58.3% to 91.7%, preintervention vs postintervention, respectively, p=0.005). CONCLUSIONS: Use of DSNS to replace breakfast and as an afternoon snack improves both glycemic control and behavioral factors related to dietary management of diabetes. TRAIL REGISTRATION NUMBER: NCT04230889.
format Online
Article
Text
id pubmed-7389484
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-73894842020-08-11 Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study Mustad, Vikkie A Hegazi, Refaat A Hustead, Deborah S Budiman, Erwin S Rueda, Ricardo Maki, Kevin Powers, Margaret Mechanick, Jeffrey I Bergenstal, Richard M Hamdy, Osama BMJ Open Diabetes Res Care Clinical Care/Education/Nutrition INTRODUCTION: This pilot study evaluated the impact of a diabetes-specific nutritional shake (DSNS) used twice daily by people with type 2 diabetes (T2D) on glycemic response assessed by continuous glucose monitoring (CGM). RESEARCH DESIGN AND METHODS: Adults (n=81) with T2D managed by oral medications were studied in a randomized, open-label, three-group parallel study design. The study was conducted in two phases over 14 days: Baseline (days 1–6), during which study participants consumed their habitual self-selected diets (SSD), followed by the Intervention (days 7–14), during which participants were randomized as follows: (1) SSD group received no study product (n=32); (2) DSNS breakfast/afternoon snack (Bkfst/AS) group consumed one DSNS as a breakfast meal replacement and a second to replace their mid-afternoon snack (n=24); (3) DSNS breakfast/prebed snack (Bkfst/PBS) group consumed one DSNS as a breakfast meal replacement and added a second as a prebed snack (n=25). Glucose was assessed by CGM throughout the study. Additionally, participants were asked about snacking behaviors, cravings, and other questions related to the use of DSNS as meal replacements and snacks. RESULTS: All groups reduced their postprandial glycemic response (positive area under the curve (pAUC, mg/min*dL(−1))) and adjusted peak value (mg/dL) when compared with the baseline phase. Participants consuming DSNS in place of their usual breakfast showed greater reductions in pAUC compared with the SSD group (p=0.008) for the DSNS Bkfst/AS group with a trend (p=0.069) for the DSNS Bkfst/PBS group. Adjusted peak value showed greater reductions in both DSNS groups as compared with the SSD group (p=0.002 for DSNS Bkfst/AS and p=0.010 for DSNS Bkfst/PBS). Nocturnal glucose variability was significantly decreased during the intervention phase compared with baseline phase in the DSNS Bkfst/AS group (p=0.020), with no significant differences between groups. After intervention, the DSNS Bkfst/AS group had a significantly lower percentage of participants (17%) reporting cravings for starchy meals/sides compared with before the study (33%) (p=0.046). This group also reported a significant increase in confidence in choosing foods to control their diabetes (from 58.3% to 91.7%, preintervention vs postintervention, respectively, p=0.005). CONCLUSIONS: Use of DSNS to replace breakfast and as an afternoon snack improves both glycemic control and behavioral factors related to dietary management of diabetes. TRAIL REGISTRATION NUMBER: NCT04230889. BMJ Publishing Group 2020-07-27 /pmc/articles/PMC7389484/ /pubmed/32718934 http://dx.doi.org/10.1136/bmjdrc-2020-001258 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Clinical Care/Education/Nutrition
Mustad, Vikkie A
Hegazi, Refaat A
Hustead, Deborah S
Budiman, Erwin S
Rueda, Ricardo
Maki, Kevin
Powers, Margaret
Mechanick, Jeffrey I
Bergenstal, Richard M
Hamdy, Osama
Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study
title Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study
title_full Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study
title_fullStr Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study
title_full_unstemmed Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study
title_short Use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study
title_sort use of a diabetes-specific nutritional shake to replace a daily breakfast and afternoon snack improves glycemic responses assessed by continuous glucose monitoring in people with type 2 diabetes: a randomized clinical pilot study
topic Clinical Care/Education/Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7389484/
https://www.ncbi.nlm.nih.gov/pubmed/32718934
http://dx.doi.org/10.1136/bmjdrc-2020-001258
work_keys_str_mv AT mustadvikkiea useofadiabetesspecificnutritionalshaketoreplaceadailybreakfastandafternoonsnackimprovesglycemicresponsesassessedbycontinuousglucosemonitoringinpeoplewithtype2diabetesarandomizedclinicalpilotstudy
AT hegazirefaata useofadiabetesspecificnutritionalshaketoreplaceadailybreakfastandafternoonsnackimprovesglycemicresponsesassessedbycontinuousglucosemonitoringinpeoplewithtype2diabetesarandomizedclinicalpilotstudy
AT husteaddeborahs useofadiabetesspecificnutritionalshaketoreplaceadailybreakfastandafternoonsnackimprovesglycemicresponsesassessedbycontinuousglucosemonitoringinpeoplewithtype2diabetesarandomizedclinicalpilotstudy
AT budimanerwins useofadiabetesspecificnutritionalshaketoreplaceadailybreakfastandafternoonsnackimprovesglycemicresponsesassessedbycontinuousglucosemonitoringinpeoplewithtype2diabetesarandomizedclinicalpilotstudy
AT ruedaricardo useofadiabetesspecificnutritionalshaketoreplaceadailybreakfastandafternoonsnackimprovesglycemicresponsesassessedbycontinuousglucosemonitoringinpeoplewithtype2diabetesarandomizedclinicalpilotstudy
AT makikevin useofadiabetesspecificnutritionalshaketoreplaceadailybreakfastandafternoonsnackimprovesglycemicresponsesassessedbycontinuousglucosemonitoringinpeoplewithtype2diabetesarandomizedclinicalpilotstudy
AT powersmargaret useofadiabetesspecificnutritionalshaketoreplaceadailybreakfastandafternoonsnackimprovesglycemicresponsesassessedbycontinuousglucosemonitoringinpeoplewithtype2diabetesarandomizedclinicalpilotstudy
AT mechanickjeffreyi useofadiabetesspecificnutritionalshaketoreplaceadailybreakfastandafternoonsnackimprovesglycemicresponsesassessedbycontinuousglucosemonitoringinpeoplewithtype2diabetesarandomizedclinicalpilotstudy
AT bergenstalrichardm useofadiabetesspecificnutritionalshaketoreplaceadailybreakfastandafternoonsnackimprovesglycemicresponsesassessedbycontinuousglucosemonitoringinpeoplewithtype2diabetesarandomizedclinicalpilotstudy
AT hamdyosama useofadiabetesspecificnutritionalshaketoreplaceadailybreakfastandafternoonsnackimprovesglycemicresponsesassessedbycontinuousglucosemonitoringinpeoplewithtype2diabetesarandomizedclinicalpilotstudy